Craig S Parzynski
Overview
Explore the profile of Craig S Parzynski including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
52
Citations
681
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Loftus J, Miller B, Parzynski C, Alvir J, Chen Y, Jhingran P, et al.
Ther Adv Endocrinol Metab
. 2025 Feb;
16:20420188241308446.
PMID: 39936080
• Children with growth deficiency (GHD) are often prescribed a growth called to help them grow. • As prescribed, needs to be injected once a day under the skin. Some...
2.
Hsu W, Crowley A, Parzynski C
BMC Med Res Methodol
. 2024 Sep;
24(1):203.
PMID: 39272007
Background: Evaluating outcome reliability is critical in real-world evidence studies. Overall survival is a common outcome in these studies; however, its capture in real-world data (RWD) sources is often incomplete...
3.
Hao Y, Hsu W, Parzynski C, Degtyarev E, Hampson L, Masood A, et al.
J Comp Eff Res
. 2023 Jun;
12(7):e220173.
PMID: 37345672
To contextualize the effectiveness of tisagenlecleucel versus real-world standard of care (SoC) in relapsed/refractory follicular lymphoma. A retrospective indirect matched comparison study using data from the phase II ELARA trial...
4.
Reinhardt S, Clark K, Xin X, Parzynski C, Riello Iii R, Sarocco P, et al.
Circ Cardiovasc Qual Outcomes
. 2022 Jul;
15(7):e008069.
PMID: 35861780
Background: Despite growing interest in value-based models, utilization patterns and costs for heart failure (HF) admissions are not well understood. We sought to characterize Medicare spending for patients with HF...
5.
Loftus J, Miller B, Parzynski C, Alvir J, Chen Y, Jhingran P, et al.
Endocr Pract
. 2022 Mar;
28(6):565-571.
PMID: 35263660
Objective: Recombinant human growth hormone (somatropin) is recommended for children with growth hormone deficiency (GHD) to normalize adult height. Prior research has indicated an association between adherence to somatropin and...
6.
Bourdillon P, Parzynski C, Minges K, Curtis J, Desai N
J Card Fail
. 2021 Oct;
28(1):154-160.
PMID: 34628015
Background: The Department of Justice (DOJ) investigated implantable cardioverter-defibrillators (ICDs) not meeting the Centers for Medicare & Medicaid Services National Coverage Determination (NCD) criteria, resulting in increased adherence to the...
7.
Daimee U, Aslam F, Parzynski C, Desai N, Curtis J
Am J Cardiol
. 2021 Jul;
155:64-71.
PMID: 34315569
Primary prevention implantable cardioverter-defibrillators (ICDs) in patients with recent myocardial infarction or coronary revascularization and those with newly diagnosed or severe heart failure (HF) are considered non-evidence-based, as defined by...
8.
Llanos-Chea F, Jelani Q, Trejo-Paredes C, Curtis J, Parzynski C, Huang J, et al.
J Am Coll Cardiol
. 2021 Mar;
77(10):1374-1375.
PMID: 33706882
No abstract available.
9.
Dhruva S, Ross J, Mortazavi B, Hurley N, Krumholz H, Curtis J, et al.
JAMA Netw Open
. 2021 Feb;
4(2):e2037748.
PMID: 33616664
Importance: Mechanical circulatory support (MCS) devices, including intravascular microaxial left ventricular assist devices (LVADs) and intra-aortic balloon pumps (IABPs), are used in patients who undergo percutaneous coronary intervention (PCI) for...
10.
Ahmed I, Merchant F, Curtis J, Parzynski C, Lampert R
Am Heart J
. 2021 Jan;
235:44-53.
PMID: 33503408
Background: Whether insurance status influences practice patterns in implantable cardioverter-defibrillators (ICDs) and cardiac resynchronization therapy (CRT) defibrillators, when indicated, is not known. Methods And Results: We analyzed the NCDR ICD...